P-287Nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine as first-line therapy in patients with metastatic pancreatic adenocarcinoma (mPAC): a randomized, open-label phase 2 study. (21st June 2016)

Record Type:: Journal Article
Title:: P-287Nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine as first-line therapy in patients with metastatic pancreatic adenocarcinoma (mPAC): a randomized, open-label phase 2 study. (21st June 2016)
Main Title:: P-287Nanoliposomal irinotecan (nal-IRI)-containing regimens versus nab-paclitaxel plus gemcitabine as first-line therapy in patients with metastatic pancreatic adenocarcinoma (mPAC): a randomized, open-label phase 2 study
Authors:: Andrew, Dean
Ramesh, Ramanathan
Brooke, Belota
Bruce, Belanger
Deyaa, Adib
Eliel, Bayever
Li-Tzong, Chen
Abstract:
Is Part Of:: Annals of oncology. Volume 27(2016)Supplement 2
Journal:: Annals of oncology
Issue:: Volume 27(2016)Supplement 2
Issue Display:: Volume 27, Issue 2 (2016)
Year:: 2016
Volume:: 27
Issue:: 2
Issue Sort Value:: 2016-0027-0002-0000
Page Start:: ii84
Page End:: ii84
Publication Date:: 2016-06-21
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdw199.277 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12573.xml